OncoLink provided daily online reports from the Chemotherapy Foundation Symposium in New York City on November 12-14, 2003. For those users interested in obtaining CME for this program, please enter the CME portion of this course. To receive CME for each day, you must view all 10 reports and fax the required documentation at the conclusion of the reviews.
Dec 10, 2012 - Adding bevacizumab to chemotherapy for the postsurgical treatment of triple-negative breast cancer does not significantly improve invasive disease-free survival compared with chemotherapy alone, according to a study presented at the annual San Antonio Breast Cancer Symposium, held from Dec. 4 to 8.
Apr 20, 2014